HIS modelling and simulation based cost-benefit analysis of a telemedical system for closed-loop diabetes therapy

被引:9
|
作者
Bott, Oliver J. [1 ]
Hoffmann, Ina [1 ]
Bergmann, Joachim [1 ]
Gusew, Nathalie [1 ]
Schnell, Oliver [2 ]
Gomez, Enrique J. [3 ]
Hernando, M. Elena [3 ]
Kosche, Patrick [4 ]
von Ahn, Christian [4 ]
Mattfeld, Dirk C. [4 ]
Pretschner, Dietrich P. [1 ]
机构
[1] Tech Univ Carolo Wilhelmina Braunschweig, Inst Med Informat, D-38106 Braunschweig, Germany
[2] Diabet Res Inst, Munich, Germany
[3] Univ Politecn Madrid, Bioengn & Telemed Grp, E-28040 Madrid, Spain
[4] Tech Univ Carolo Wilhelmina Braunschweig, Inst Econ Sci, Braunschweig, Germany
关键词
Health information systems; Cost-benefit analysis; Model; Simulation; Telemedicine; Diabetes mellitus; Insulin infusion system;
D O I
10.1016/j.ijmedinf.2007.06.002
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Objectives: INCA (Intelligent Control Assistant for Diabetes) is an EU funded project aimed at improving diabetes therapy by creating a personal closed-loop system interacting with telemedical remote control. This study aims at identifying and applying suitable methods for a cost-benefit analysis from the perspective of the payor for health services. Methods: For cost analysis MOSAIK-M was used, a method and tool for health information systems analysis and design. Two MOSAIK-M models were created describing conventional insulin pump based diabetes care (CSII), and INCA based diabetes care. Both models were parameterised with costs and simulated to determine yearly costs of diabetes management and treatment for a patient with no diabetes related complications. Probability of developing complications and their duration were determined based on the Archimedes model. It was parameterised with results of a clinical study concerning HbA1c-value changes using the INCA system compared with conventional CSII. The simulation results in form of years of disease within a 30-year time frame were multiplied with corresponding treatment costs. Results: Yearly costs of conventional insulin CSII for a diabetes type 1 patient are D 5908 (German health care system). Using INCA based on the clinical study setting would raise yearly costs by (sic)2233. 24% of the INCA costs are generated by the continuous blood glucose measurement device, 5% by IT devices and services. Considering also diabetes related complications in a 30-year time frame and HbA1c value reductions from 7.9 and 7.6% (conventional CSII) to 7.5 and 7.3% (INCA) reduces the additional costs of INCA to D 2102 and (sic)2162. Conclusions: The approach produces an estimation of a lower bound for cost savings concerning the treatment of diabetes related complications in a 30-year time frame. These savings alone do not prove cost efficiency of the INCA approach. Further work is needed to improve the approximation and to include indirect and intangible costs. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:S447 / S455
页数:9
相关论文
共 50 条
  • [1] Simulation based cost-benefit analysis of a telemedical system for closed-loop insulin pump therapy of diabetes
    Bott, Oliver J.
    Hoffmann, Ina
    Bergmann, Joachim
    Kosche, Patrick
    von Ahn, Christian
    Mattfeld, Dirk C.
    Schnell, Oliver
    Pretschner, Dietrich P.
    [J]. UBIQUITY: TECHNOLOGIES FOR BETTER HEALTH IN AGING SOCIETIES, 2006, 124 : 435 - +
  • [2] A fuzzy cost-benefit function to select economical products for processing in a closed-loop supply chain
    Pochampally, KK
    Gupta, SM
    Cullinane, TP
    [J]. ENVIRONMENTALLY CONSCIOUS MANUFACTURING III, 2004, 5262 : 20 - 29
  • [3] The Cost of Control: Cost- effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth
    Pease, Anthony
    Callander, Emily
    Zomer, Ella
    Abraham, Mary B.
    Davis, Elizabeth A.
    Jones, Timothy W.
    Liew, Danny
    Zoungas, Sophia
    [J]. DIABETES CARE, 2022, 45 (09) : 1971 - 1980
  • [4] A Closed-loop Control System Based on the Logistics Cost of Supply Chain
    Xiong Ping
    Yang Ming-zhong
    [J]. PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON INFORMATION MANAGEMENT, INNOVATION MANAGEMENT AND INDUSTRIAL ENGINEERING, VOL II, 2008, : 3 - 6
  • [5] Continuous drug infusion for diabetes therapy: A closed-loop control system design
    Chen, Jiming
    Cao, Kejie
    Sun, Youxian
    Xiao, Yang
    Su, Xu
    [J]. EURASIP JOURNAL ON WIRELESS COMMUNICATIONS AND NETWORKING, 2008, 2008 (1)
  • [6] Continuous Drug Infusion for Diabetes Therapy: A Closed-Loop Control System Design
    Jiming Chen
    Kejie Cao
    Youxian Sun
    Yang Xiao
    Xu(Kevin) Su
    [J]. EURASIP Journal on Wireless Communications and Networking, 2008
  • [7] Research and Innovative Methodology on Closed-Loop Analysis & Improvement Mechanism Based on Cost of Quality System
    Liang B.
    Zhou T.
    Hu Y.
    [J]. International Journal of Information and Management Sciences, 2022, 33 (02): : 167 - 182
  • [8] Modelling and Closed-Loop System Identification of a Quadrotor-Based Aerial Manipulator
    Dube, Chioniso
    Pedro, Jimoh O.
    [J]. 6TH INTERNATIONAL CONFERENCE ON MECHATRONICS AND CONTROL ENGINEERING (ICMCE 2017), 2018, 1016
  • [9] Simulation and Analysis of Pressure Closed-Loop Control of Closed Slewing System of Supersized Hydraulic Excavator
    Sun, Bo
    Yang, Haifeng
    Ding, Haigang
    Han, Guozhi
    Wang, Bo
    Li, Zong
    Zhao, Jiyun
    [J]. PROCEEDINGS OF 2015 INTERNATIONAL CONFERENCE ON FLUID POWER AND MECHATRONICS - FPM 2015, 2015, : 176 - 180
  • [10] Simulation of AC motor speed closed-loop control system based on SIMULINK
    Li, Wen
    Xu, Zhi-Chao
    Ding, Ming-Yan
    [J]. Shanghai Jiaotong Daxue Xuebao/Journal of Shanghai Jiaotong University, 2012, 46 (SUPPL. 1): : 83 - 86